Physiology of mechanotransduction: How do muscle and bone "talk" to one another?

Clinical Reviews in Bone and Mineral Metabolism

Volumn 12, Issue 2, 2014, Pages 77-85

  Isaacson, Janalee ^a,b   Brotto, Marco ^a,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b JOHNSON COUNTY COMMUNITY COLLEGE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone muscle cross talk; Bones; Cross talk; Mechanostat; Muscles; Musculoskeletal; Myokines; Osteoporosis; Sarcopenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CXCL1 CHEMOKINE; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 6; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; NITRIC OXIDE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PROSTAGLANDIN; SCLEROSTIN;

ADIPOCYTE; ADIPOSE TISSUE; AGING; ARTICLE; BIOMECHANICS; BONE; BONE DENSITY; CELL INTERACTION; CHRONIC OSTEOMYELITIS; HUMAN; INSULIN RESISTANCE; MECHANOTRANSDUCTION; MUSCLE; MUSCULOSKELETAL DISEASE; OSSIFICATION; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PANCREAS ISLET BETA CELL; SARCOPENIA; SKELETAL MUSCLE; SYSTEMS BIOLOGY;

EID: 84903649414     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-013-9152-3     Document Type: Article

References (68)

1. Ioannidis I. The road from obesity to type 2 diabetes. Angiology. 2008;59(Supp 2):39S-43S.
2. Berg AH, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947-53. (Pubitemid 32756433)
3. Sell H, Dietze-Schroeder D, Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab. 2006;17(10):416-22. (Pubitemid 44780130)
4. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. AJP Cell Physiol. 2011;302:C327-59.
5. Begg DP, Woods SC. The endocrinology of food intake. Nat Rev Endocrinol. 2013;9:584-97.
6. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years live with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163-96.
7. Frost HM. Perspectives: a proposed general model of the "mechanostat" (suggestions from a new skeletal-biologic paradigm). Anat Rec. 1996;244:139-47.
8. Marotti G, Ferretti M, Muglia MA, Palumbo C, Palazzini S. A quantitative evaluation of osteoblast-osteocyte relationships on growing endosteal surface of rabbit tibiae. Bone. 1992;13:363-8.
9. Tanaka K, Matsuo T, Ohta M, Sato T, Tezuka K, Nijweide PJ, et al. Time-lapse microcinematography of osteocytes. Miner Electrolyte Metab. 1995;21:189-92.
10. Klein-Nulend J, van der Plas A, Semeins CM, Ajubi NE, Frangos JA, Nijweide PJ, et al. Sensitivity of osteocytes to biomechanical stress in vitro. FASB J. 1995;9:441-5.
11. Burger EH, Klein-Nulend J. Mechanotransduction in bone - role of the lacuna-canalicular network. FASEB J. 1999;13:101-12.
12. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, et al. Osteocyte control of one formatin via sclerostin, a novel BMP antagonist. EMBO J. 2003;22:6267-76. (Pubitemid 37522584)
13. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiologyical role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561-8. (Pubitemid 38542505)
14. Bonewald LF, Wacker MJ. FGF23 production by osteocytes. Pediatr Nephrol. 2012;28:563-8.
15. Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J. 2011;25:2551-62.
16. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2:389-406. (Pubitemid 34436569)
17. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner. 1991;14: 237-50.
18. Ducy P, Desbois C, Boyce B, Pinero G, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996;382:448-52. (Pubitemid 26264860)
19. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-54. (Pubitemid 27516177)
20. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-69. (Pubitemid 47208519)
21. Agas D, Marchetti L, Hurley MM, Sabbieti MG. Prostablandin F2α: a bone remodeling mediator. J Cell Physiol. 2013;228:25-9.
22. Mo C, Romero-Suarez S, Brotto MA. Pge2 accelerates myogenesis of C2C12 myoblasts. Biophys J. 2011;100:288a.
23. Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012;481:314-20.
24. Orestes-Cardoso SM, Nefussi JR, Hotton D, Mesbah M, Orestes-Cardoso MDS, Robert B, et al. Postnatal Msx1 expression pattern in craniofacial, axial, and appendicular skeleton of transgenic mice from the first week until the second year. Dev Dyn. 2001;221:1-13.
25. Pearson OM, Lieberman DE. The aging of Wolff's law: ontogeny and responses to mechanical loading in cortical bone. Am J Phys Anthropol. 2004;125:63-99.
26. Lang TF. The bone-muscle relationship in men and women. J Osteoporos. 2011;2011:1-4.
27. Zanchetta JR, Plotkin H, Filgueira MLA. Bone mass in children: normative values for the 2-20-year-old population. Bone. 1995;16:S393-9.
28. Wang Q, Alen M, Nicholson P, Suominen H, Koistinen A, Kroger H, et al. Weight-bearing, muscle loading and bone mineral accrual in pubertal girls - a 2-year longitudinal study. Bone. 2007;40:1196-202. (Pubitemid 46550972)
29. Hirokawa N, Niwa S, Tanaka Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 2010;68:610-38.
30. Gomez-Pinilla F. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol. 2002;88:2187-95. (Pubitemid 35346024)
31. Goldspink DF, Goldspink G. The role of passive stretch in retarding muscle atrophy. In: Nix WA, Vrbova G, editors. Electrical stimulation and neuromuscular disorders. Berlin: Springer; 1986. p. 91-100.
32. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve. 1997;20:815-22. (Pubitemid 27250667)
33. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003;24:113-9. (Pubitemid 37323614)
34. Steensberg A, Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529:237-42.
35. Andersen K, Pedersen B. The role of inflammation in vascular insulin resistance with focus on IL-6. Horm Metab Res. 2008;40:635-9.
36. Keller C. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 2001;15(14):2748-50.
37. Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab. 2007;32:833-9.
38. Pedersen BK, Akerstrom TCA, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol. 2007;103:1093-8. (Pubitemid 47358897)
39. Matthews VB, Astrom MB, Chan MHS, Bruce CR, Krabbe KS, Prelovsek O, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009;52:1409-18.
40. Pedersen L, Olsen CH, Pedersen BK, Hojman P. Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle. AJP Endocrinol Metab. 2012;302:E831-40.
41. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 2002;161:895-907. (Pubitemid 34988377)
42. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature. 2008;454:961-7.
43. Hee Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98(12):4899-907.
44. Chan JKK, Harry L, Williams G, Nanchahal J. Soft-tissue reconstruction of open fractures of the lower limb: muscle versus fasciocutaneous flaps. Plast Reconstr Surg. 2012;130:284e-95e.
45. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature. 1997;387:83-90. (Pubitemid 27202654)
46. Jouliaekaza D, Cabello G. The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol. 2007;7:310-5. (Pubitemid 46738500)
47. Zimmers TA. Induction of cachexia in mice by systemically administered myostatin. Science. 2002;296:1486-8. (Pubitemid 34553097)
48. Hamrick MW, McPherron AC, Lovejoy CO. Bone mineral content and density in humerus of adult myostatin-deficient mice. Calcif Tissue Int. 2002;71:63-8. (Pubitemid 36934778)
49. Hamrick MW. Increased bone mineral density in the femora of GDF8 knockout mice. Anat Rec. 2003;272A:388-91. (Pubitemid 37238335)
50. Hamrick MW, Samaddar T, Pennington C, McCormick J. Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J Bone Miner Res. 2005;21:477-83.
51. Morissette MR, Stricker JC, Rosenberg MA, Buranasombati C, Levitan EB, Mittleman MA, et al. Effects of myostatin deletion in aging mice. Aging Cell. 2009;8:573-83.
52. Coiro V, Volpi R, Cataldo S, Magotti MG, Maffei ML, Giumelli C, et al. Effect of physiological exercise on osteocalcin levels in subjects with adrenal incidentaloma. J Endocrinol Invest. 2012;35:357-8.
53. Centers for Disease Control and Prevention (US); Prevalence of obesity among older adults in the United States, 2007-2010. 2012. (NCHS Data Brief; no. 106).
54. Beltran-Sanchez H, Harhay MO, Harhay MM, McElliogott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013;62(8):697-703.
55. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231-43. (Pubitemid 32296061)
56. Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123-48. (Pubitemid 43588859)
57. Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr. 2006;96(5):895-901. (Pubitemid 46454567)
58. Kalantar-Zadeh K, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP. Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle. 2013;4:89-94.
59. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437-48. (Pubitemid 30389235)
60. Jensen GL, Friedmann JM. Obesity is associated with functional decline in community-dwelling rural older persons. J Am Geriatr Soc. 2002;50(5):918-23. (Pubitemid 34496691)
61. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010;5(5):1-7.
62. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes. Diabetes Care. 2010;33(7):1497-9.
63. Magkos F, Wang X, Mittendorfer B. Metabolic actions of insulin in men and women. Nutrition. 2010;26(7-8):686-93.
64. Lee CG, Boyko EJ, Strotmeyer ES, Lewis CE, Cawthon PM, Hoffman AR, et al. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc. 2011;59:1217-24.
65. Hofbauer LG, Brueck C, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. JBMR. 2007;22(9):1317-28. (Pubitemid 351339677)
66. Strotmeyer ES, Cauley JA. Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes. 2007;14:429-35. (Pubitemid 350059352)
67. Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009;84:45-55.
68. Hamann C, Kirschner S, Gunther KP, Hofbauer LC. Bone sweet bone - osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol. 2012;8:297-305.